We view this as a weight loss journey with phases
Potential Future Users: Reasons for considering usage, weight loss/health goals, likelihood of use, and what factors will be most influential in determining usage
Phase 2 trial data showed average weight loss of up to 24.2% at 48 weeks, while the newer Phase 3 trial data showed 28.7% average weight loss at 68 weeks on the 12mg dose
confirm with your prescriber or specialist service
Peptide-based drug market & clinical trial Over the past two decades, the number of approved peptide drugs has surpassed 60, with more drugs undergoing global approval processes (Fig
Answer 6 questions and see which protocol patients with similar goals chose: single peptide at $445, Wolverine Stack at $795, or a custom multi-peptide cycle